Navigation Links
Breast Cancer Drug Not Tied to Cognitive Decline: Study
Date:9/2/2008

Researchers say finding is 'good news' for postmenopausal women taking anastrozole

TUESDAY, Sept. 2 (HealthDay News) -- Contrary to previous study results, the cancer prevention drug anastrozole does not appear to cause impairment of cognitive performance, a new study found.

Anastrozole has been shown to be superior to tamoxifen in preventing breast cancer recurrence in postmenopausal women. But some "cross-sectional" studies have suggested that endocrine therapies such as anastrozole are associated with poorer performance on verbal memory and processing tasks.

For the new study, published in the October edition of The Lancet Oncology, researchers randomly assigned postmenopausal women to receive anastrozole or a placebo daily for five years.

Before the study began, and for six months and 24 months after starting treatment, a subset of 227 of the women underwent tests to measure their cognitive performance, including auditory verbal tasks, logical memory tasks, spatial span tests, and verbal fluency assessments.

There was no difference between the anastrozole or placebo groups at six months or 24 months in changes in attention or memory, or in the number of women who experienced cognitive decline in three or more cognitive tasks.

The only difference between the groups was that at the 24-month time point, significantly more women in the anastrozole group reported experiencing hot flushes.

The authors of the study pointed out that more research is needed to determine the longer-term effects of anastrozole, but said their findings were good news for women who take the medication.

"These findings should be reassuring in the short term for postmenopausal women being treated with anastrozole, their clinicians and carers," they wrote.

This study was part of the International Breast Intervention Study.

More information

The U.S. National Cancer Institute has more about anastrozole.



-- Krisha McCoy



SOURCE: The Lancet Oncology, news release, Sept. 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Hospitals provide formula sample packs while medical organizations encourage breastfeeding
2. Komen Travels to Republican Convention to Raise Awareness of Breast Cancer Issues
3. Superbug breast infections controllable in nursing mothers, UT Southwestern researchers find
4. Komen Travels to Democratic Convention in Denver to Raise Awareness of Breast Cancer Issues
5. Taking Codeine While Breast-Feeding May Harm Infant
6. Breastfeeding, other factors may affect risk of breast cancer type
7. Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry
8. Risk of Breast Cancer Relapse Can Linger
9. Risk assessment plays key role in long-term treatment of breast cancer
10. MedexSupply Announces the Release of the ADC Limited Edition Pink Ribbon Stethoscope, With Proceeds Being Donated to Breast Cancer Research
11. Breast-Feeding: The Stress Buster That Lasts for Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media ... Janet Yellen and company to wait until March 2017 for an interest rate increase, ... Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... NORTH CHESTERFIELD, Va. , May 25, 2016 ... commercially-available next-generation sequencing test for wounds and infections. ... fungi, ALL parasites, and select viruses. The test ... infected area. David G. ... advanced molecular testing to facilitate wound healing: "We ...
Breaking Medicine Technology: